Osteolysis may occur following lumbar interbody fusion procedures in which recombinant human bone morphogenetic protein-2, more commonly known as rhBMP-2, is used. The actual incidence of this process is unknown. Osteolysis results from an osteoclastic, rather than an osteoblastic response to rhBMP-2 and its carrier on trabecular vertebral bone, early in the sequence of bone graft healing. This osteoclastic response may represent an idiosyncratic reaction in those affected. The patient usually does well in the immediate postoperative period with resolution of their preoperative complaints of axial and radicular pain. However, at 4 to 12 weeks following the index surgery, the patient experiences a recurrence of severe back and radicular pain corresponding to the dermatomal level(s) operated upon. Laboratory studies including erythrocyte sedimentation rate, C reactive protein, and cultures are negative for infection. Imaging studies show areas of bone destruction and cyst formation containing fluid. In the majority of postoperative patients with osteolysis, there is an osteoblastic healing response with symptom resolution. Supportive, nonoperative care is usually effective in managing the patient.
INTRODUCTION
Bone morphogenetic protein (BMP) has been used for several years as a substitute for autogenous iliac crest bone graft in fracture repair augmentation and spinal fusion procedures. Cahill et al 1 recently reported on the complications and hospital costs associated with the use of BMP in spinal fusions. Several investigators have noted osteolysis following lumbar interbody fusion procedures with rhBMP-2. 2-8 Osteolysis has not occurred in patients undergoing a posterior lateral fusion in which rhBMP-2 has been used. 9 Swelling and edema following its use in anterior cervical fusions has lead to serious complications. [10] [11] [12] Perioperative radiculitis, hematoma and seroma formation, as well as wound infection have all occurred in patients undergoing transforaminal lumbar interbody (TLIF) with rhBMP-2. 
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Preparation of the Interbody Fusion Site
Removal of the remnants of the intervertebral disk with portions of the annulus and anterior and posterior longitudinal ligaments is common to all but the AxiaLIF procedure, which is done via transosseous axial channel through the sacrum. The end plates are denuded of any remaining surface cartilage, to the level of subchondral bleeding bone. An attempt is made to distract and realign the interspace before insertion of the polyether ether ketone (PEEK) or metallic interbody cages. The cages may be filled with autogenous bone, allograft bone, or various bone graft extenders, such as tricalcium phosphate or hydroxylapatite composites, as well as rhBMP-2 applied to bovine collagen sponges. Villavicencio et al 2, 3 postulated that placing rhBMP-2 near exposed endplate-marrow defects would result in osteolysis. Various barrier sealants have been recommended to prevent migration of rhBMP-2 into the epidural space to prevent an inflammatory response and heterotopic bone formation around the dura. 4 In most cases, the cage or anterior implant is reinforced with pedicle screw fixation.
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Clinical and Radiographic Findings
There are numerous case reports of patients undergoing interbody fusions with rhBMP-2 who have experienced complications in the early postoperative period. Marked swelling in the soft tissues of the neck leading to dyspnea and dysphagia following the use of rhBMP-2 in anterior cervical fusions has been reported. [10] [11] [12] To this effect, the FDA issued a physician warning in 2009 detailing the potential for rhBMP-2 to cause such problems. 24 Patients undergoing interbody lumbar fusions with rhBMP-2 can experience the onset of severe axial and radicular pain within 4 to 12 weeks postoperatively. Typically, subsequent infectious work-ups are negative, including white blood cell count, erythrocyte sedimentation rate, C reactive protein and cultures. Vaidya et al 25 reported on the complications experienced by ten ALIF and twentysix TLIF or PLIF patients in whom rhBMP-2 was used. Several of these patients required revision surgery because of worsening neurologic complaints and subsidence of their interbody cages. Plain radiographs of the lumbosacral spine are typically not helpful in detecting osteolysis. Cage, rod and screw constructs often fail to maintain correction because the bone in which they are placed has undergone osteolysis. Areas of edema and cysts containing fluid are best seen on magnetic resonance imaging (MRI) studies (Figs 1A to 2B). Computed tomography (CT) scans show areas of bone loss in the vertebral body and around the anterior implants and pedicle screws (Figs 3A and B) . Some of these osteolytic areas can be quite extensive and tract through perforations in the endplate to adjacent vertebral levels. Fluid-filled cysts in juxta position to nerve roots and the dura may result in radicular complaints. 
Cause of Osteolysis
There is speculation that some patients experience an idiosyncratic reaction to rhBMP-2. patients who presented with worsening back pain and variable radicular pain at 1 to 3 months following a TLIF in which rhBMP-2 was used. They noted that the osteolytic defects filled in and symptoms resolved within 3 months without formal treatment. They suggested that a dosedependent cellular cascade activation of osteoclasts over the osteoblasts may have occurred as a result of the rhBMP-2 induced inflammatory effects. In the original reports by Burkus et al 18, 21 on the use of rhBMP-2 in anterior interbody fusions with femoral ring allografts, cortical allograft dowels and tapered titanium cages, they noted radiolucent lines around some of the implants. Osteolysis most likely occurred in some of these patients, but was not investigated with either MRI or CT scans. Mummaneni et al 22 In four patients, a seroma in the area of the neural foramen caused nerve root compression. Six patients had persistent radiculopathy of unknown etiology found in their imaging studies. These patients improved with oral steroids and other medications on average at 4.0 ± 2.8 months after their index surgery. In order to minimize the potential for postoperative radiculitis and radiculopathy, Villavicencio et al 2, 3 recommended placing the rhBMP-2 anterior to the structural allografts in TLIF procedures. Rihn et al 4 noted a decrease in postoperative radiculitis with the use of a hydrogel sealant posterior to the interbody cage. Reported rates of postoperative radiculitis in TLIF procedures using autograft are 2 to 7%. [2] [3] [4] The reported rate of radiculitis in TLIF procedures in which rhBMP-2 is used ranges from 7 to 14%. [2] [3] [4] [5] [6] [7] [8] In summary, the use of rhBMP-2 appears to be safe in applications where it does not incite an osteoclastic inflammatory response. However, one must be cautious when using rhBMP-2 in interbody fusion applications in which direct contact is made with the exposed trabecular bone of the vertebral body, as often occurs in ALIF, PLIF, TLIF, XLIF and AxiaLIF procedures. Although the osteoclastic response is usually of short duration, instability and loss of correction can occur and necessitate further reconstructive surgery. Management of radiculitis and radiculopathy may require several months of supportive care.
